Molecular Therapy · 2010 · 114 citations · 46 references
Life SciencesBiotechnologyMolecular BiologyCell TherapyGenetic EngineeringStem Cell BiotechnologyEmbryonic Stem Cell ManipulationEmbryonic Stem CellsGene Delivery To Stem CellsPluripotent Stem CellsStem Cell Gene TherapyStem Cell ReprogrammingAdeno-associated Viral VectorsAdenoviral VectorsEmbryonic Stem Cell Gene TargetingHuman Embryonic Stem CellsHuman Induced Pluripotent Stem Cell ModelsInduced Pluripotent Stem Cell ModelsInduced Pluripotent Stem CellsLesch-nyhan Syndrome
Precise genetic manipulation of human pluripotent stem cells will be required to realize their scientific and therapeutic potential. Here, we show that adeno-associated virus (AAV) gene targeting vectors can be used to genetically engineer human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs). Different types of sequence-specific changes, including the creation and correction of mutations, were introduced into the human HPRT1 and HMGA1 genes (HPRT1 mutations being responsible for Lesch–Nyhan syndrome). Gene targeting occurred at high frequencies in both ESCs and iPSCs, with over 1% of all colony-forming units (CFUs) undergoing targeting in some experiments. AAV vectors could also be used to target genes in human fibroblasts that were subsequently used to derive iPSCs. Accurate and efficient targeting took place with minimal or no cytotoxicity, and most of the gene-targeted stem cells produced were euploid and pluripotent. Precise genetic manipulation of human pluripotent stem cells will be required to realize their scientific and therapeutic potential. Here, we show that adeno-associated virus (AAV) gene targeting vectors can be used to genetically engineer human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs). Different types of sequence-specific changes, including the creation and correction of mutations, were introduced into the human HPRT1 and HMGA1 genes (HPRT1 mutations being responsible for Lesch–Nyhan syndrome). Gene targeting occurred at high frequencies in both ESCs and iPSCs, with over 1% of all colony-forming units (CFUs) undergoing targeting in some experiments. AAV vectors could also be used to target genes in human fibroblasts that were subsequently used to derive iPSCs. Accurate and efficient targeting took place with minimal or no cytotoxicity, and most of the gene-targeted stem cells produced were euploid and pluripotent.
46
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Kazutoshi Takahashi, Koji Tanabe, Mari Ohnuki et al. · Cell · 2007 · 20.2K citations
Embryonic Stem Cell Lines Derived from Human Blastocysts
James A. Thomson, Joseph Itskovitz‐Eldor, Sander S. Shapiro et al. · Science · 1998 · 15.9K citations
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Junying Yu, Maxim A. Vodyanik, Kim Smuga-Otto et al. · Science · 2007 · 10.3K citations
Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences
Junying Yu, Kejin Hu, Kim Smuga-Otto et al. · Science · 2009 · 2.4K citations · Full text
Disease-Specific Induced Pluripotent Stem Cells
In‐Hyun Park, Natasha Arora, Hongguang Huo et al. · Cell · 2008 · 2.2K citations · Full text